class

First-in-class therapy targets “undruggable” protein in hard-to-treat blood cancers

4 lemurs die of human herpesvirus, including one that had been used in a 'lemur yoga' class

Record number of women join Duke-NUS as Class of 2030 brings diverse life and work experiences into medicine - EurekAlert!

AI-empowered pipeline-in-a-drug option: Insilico Medicine nominates ISM9077, potential first-in-class target Y inhibitor, as preclinical candidate (PCC) for ocular diseases, inflammatory disorders and aging - EurekAlert!

First-in-class small molecule inhibitor designed with AI support shows promise against pancreatic cancer in preclinical studies - EurekAlert!

Researchers identify class of 'oddball' meteorite that killed the dinosaurs - EurekAlert!

Megawatt-class scalable optical vortex arrays with 3,070 vortices demonstrated - EurekAlert!

NASA Selects Next Class of Space Health Postdoctoral Fellows

PKU scientists develop first-in-class drug candidate for cholestatic itch - EurekAlert!

Sanford Burnham Prebys awarded $3.9 million NIH grant to develop first-in-class non-opioid pain treatment - EurekAlert!

Class uses Minecraft as building blocks for MCAT - EurekAlert!

CHEST announces first class of certified critical care advanced practice providers awarded CCAPP Designation - EurekAlert!

Insilico Medicine receives IND approval from FDA for ISM8969, an AI-empowered potential best-in-class NLRP3 inhibitor - EurekAlert!

'Doctor Who' spin-offs ranked: From K-9 and Daleks! to 'Class', 'The Sarah Jane Adventures' and 'Torchwood'

The National Academy of Inventors welcomes 2025 Class of Fellows - EurekAlert!

Development of 1-Wh-class stacked lithium-air cells - EurekAlert!

SUMP: How a Constructive Hodge-Class Provides a Pathway to All Seven Millennium Problems (Open Paper & Code)

NASA Selects All-American 2025 Class of Astronaut Candidates

Career-switching professionals, twins and trailblazers: Duke-NUS’ Class of 2029 redefines path to medicine - EurekAlert!

Massey becomes first U.S. site to enroll patients in global Phase 2a trial of first-in-class therapy for T-cell lymphoma - EurekAlert!